Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Efficacy and immunogenicity of a veterinary vaccine candidate against tick-borne encephalitis in dogs

J. Salat, M. Hunady, P. Svoboda, L. Strelcova, P. Strakova, A. Fortova, M. Palus, D. Ruzek

. 2023 ; 41 (42) : 6150-6155. [pub] 20230915

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc24001085
E-zdroje Online Plný text

NLK ProQuest Central od 2002-01-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest) od 2002-01-01 do Před 2 měsíci
Health & Medicine (ProQuest) od 2002-01-01 do Před 2 měsíci
Family Health Database (ProQuest) od 2002-01-01 do Před 2 měsíci
Health Management Database (ProQuest) od 2002-01-01 do Před 2 měsíci
Public Health Database (ProQuest) od 2002-01-01 do Před 2 měsíci

Odkazy

PubMed 37716828
DOI 10.1016/j.vaccine.2023.09.019
Knihovny.cz E-zdroje

Tick-borne encephalitis (TBE) is a severe neuroinfection of humans. Dogs are also commonly infected with tick-borne encephalitis virus (TBEV). These infections are usually asymptomatic, but sometimes show clinical signs similar to those seen in humans and can be fatal. To date, there is no TBEV vaccine available for use in dogs. To address this need, a TBEV vaccine candidate for dogs based on inactivated whole virus antigen was developed. The safety, immunogenicity, and efficacy of the vaccine candidate were tested in mice as the preclinical model and in dogs as the target organism. The vaccine was well tolerated in both species and elicited the production of specific anti-TBEV antibodies with virus neutralising activity. Vaccination of mice provided complete protection against the development of fatal TBE. Immunisation of dogs prevented the development of viremia after challenge infection. Therefore, the developed vaccine candidate is promising to protect dogs from severe TBEV infections.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24001085
003      
CZ-PrNML
005      
20240306124636.0
007      
ta
008      
240109s2023 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.vaccine.2023.09.019 $2 doi
035    __
$a (PubMed)37716828
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Salat, Jiri $u Laboratory of Emerging Viral Infections, Veterinary Research Institute, Brno, Czech Republic; Laboratory of Arbovirology, Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic. Electronic address: jiri.salat@vri.cz
245    10
$a Efficacy and immunogenicity of a veterinary vaccine candidate against tick-borne encephalitis in dogs / $c J. Salat, M. Hunady, P. Svoboda, L. Strelcova, P. Strakova, A. Fortova, M. Palus, D. Ruzek
520    9_
$a Tick-borne encephalitis (TBE) is a severe neuroinfection of humans. Dogs are also commonly infected with tick-borne encephalitis virus (TBEV). These infections are usually asymptomatic, but sometimes show clinical signs similar to those seen in humans and can be fatal. To date, there is no TBEV vaccine available for use in dogs. To address this need, a TBEV vaccine candidate for dogs based on inactivated whole virus antigen was developed. The safety, immunogenicity, and efficacy of the vaccine candidate were tested in mice as the preclinical model and in dogs as the target organism. The vaccine was well tolerated in both species and elicited the production of specific anti-TBEV antibodies with virus neutralising activity. Vaccination of mice provided complete protection against the development of fatal TBE. Immunisation of dogs prevented the development of viremia after challenge infection. Therefore, the developed vaccine candidate is promising to protect dogs from severe TBEV infections.
650    _2
$a lidé $7 D006801
650    _2
$a zvířata $7 D000818
650    _2
$a psi $7 D004285
650    _2
$a myši $7 D051379
650    12
$a klíšťová encefalitida $x prevence a kontrola $x veterinární $7 D004675
650    _2
$a protilátky virové $7 D000914
650    12
$a virové vakcíny $7 D014765
650    _2
$a vakcinace $7 D014611
650    _2
$a imunizace $7 D007114
650    12
$a viry klíšťové encefalitidy $7 D004669
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hunady, Milan $u Bioveta, Inc., Ivanovice na Hane, Czech Republic
700    1_
$a Svoboda, Pavel $u Laboratory of Emerging Viral Infections, Veterinary Research Institute, Brno, Czech Republic; Laboratory of Arbovirology, Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic; Department of Pharmacology and Pharmacy, Faculty of Veterinary Medicine, University of Veterinary Sciences, Brno, Czech Republic
700    1_
$a Strelcova, Lucie $u Bioveta, Inc., Ivanovice na Hane, Czech Republic
700    1_
$a Strakova, Petra $u Laboratory of Emerging Viral Infections, Veterinary Research Institute, Brno, Czech Republic; Laboratory of Arbovirology, Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Fortova, Andrea $u Laboratory of Emerging Viral Infections, Veterinary Research Institute, Brno, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Palus, Martin $u Laboratory of Emerging Viral Infections, Veterinary Research Institute, Brno, Czech Republic; Laboratory of Arbovirology, Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic
700    1_
$a Růžek, Daniel, $d 1981- $u Laboratory of Emerging Viral Infections, Veterinary Research Institute, Brno, Czech Republic; Laboratory of Arbovirology, Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic. Electronic address: ruzekd@paru.cas.cz $7 stk2008441707
773    0_
$w MED00004631 $t Vaccine $x 1873-2518 $g Roč. 41, č. 42 (2023), s. 6150-6155
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37716828 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240306124631 $b ABA008
999    __
$a ok $b bmc $g 2049597 $s 1210779
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 41 $c 42 $d 6150-6155 $e 20230915 $i 1873-2518 $m Vaccine $n Vaccine $x MED00004631
LZP    __
$a Pubmed-20240109
Zpět

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace